Congratulations to the recipients of the 2023 EGFR Resisters /LUNGevity Research Award for EGFR-Positive Lung Cancer: Susumu Kobayashi (BIDMC) and Alexandre Reuben, Ph.D. (MD Anderson Cancer Center). Learn more by visiting lungevity.org/news/media-rel… #TransformingLungCancer #LUNGevityResearch

‼️WE NEED YOUR HELP‼️ This #givingtuesday, please donate to EGFR Research Fund to support life saving lung cancer research for our patient community We need to reach $400,000 in order to fund 2 crucial new projects Thank u for considering! Donate here: fundraise.lungevity.org/index.cfm?fuse…

Congratulations to our physician-scientists who have been named to Texas Medical Center Innovation’s 2024 Accelerator for Cancer Therapeutics cohort. See the list: brnw.ch/21wGz3f InnovationMap Alexandre Reuben, Ph.D. Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @wenjiang_nano Anil Sood Jian Hu #EndCancer

Congratulations to our Thoracic/HN Medical Oncology teams for a great research retreat. Excited for all of the great science and what is yet to come. #EndCancer #LCSM #HNCSM MD Anderson Cancer Center

Read our interview with Alexandre Reuben, Ph.D. as he discusses using T cells to tackle drug resistance in EGFR+ lung cancer. bit.ly/3Ijk4Js #lcsm #EGFR #lungcancer

Using T cells to Tackle Drug Resistance in EGFR+ Lung Cancer- Alexandre Reuben, Ph.D. lungevity.org/blogs/using-t-…

Together with our collaborators from Affini-T Therapeutics , we are excited to report at #AACR24 on a suite of #bestinclass #TCR therapies discovered in the Klebanoff Lab targeting the two most common driver mutations in human cancer: KRAS (G12D) and TP53 (R175). Come say hi! #Tcellpower

1/ Do precancers in #LynchSyndrome (LS) patients generate #neoantigens that could be targetable with #vaccines to intercept #cancer development before tumor formation? Check out our study published in Gastroenterology 🚨🤩 Eduardo Vilar Fahriye Duzagac gastrojournal.org/article/S0016-… 🧵👇

MD Anderson is home to hundreds of labs and thousands of scientists with expertise in different fields. We asked four of them – Drs. Lauren Colbert, Emil Schueler, Aria Vaishnavi and Moran Amit – to share what inspires them. bit.ly/3IyhejQ Lauren E. Colbert, MD MSCR Aria Vaishnavi, PhD

🚨Just published: The registration enabling clinical data set for an affinity-enhanced TCR targeting the cancer-germline antigen MAGE-4. Afami cell on track to be the *first* FDA approved TCR gene therapy and first gene therapy product for a solid cancer. thelancet.com/journals/lance…

CCIR-Immunology Trainee Seminar Series- TOMORROW, 04/03 at 12 pm! Imm students, Krithikaa Rajkumar Bhanu from Dr. Michael Curran's lab Michael A. Curran, Ph.D. and Emily Bontekoe from Dr. Alexandre Reuben’s lab Alexandre Reuben, Ph.D. will be presenting their research! Lunch will be provided.

Chad, Sarah, Brittany& Linda are all never-smokers with RET-positive #lungcancer. They are parents, siblings, friends & spouses. This is their story. #lcsm Stephen V Liu, MD Narjust Florez, MD, FASCO Vivek Subbiah, MD youtube.com/watch?v=UJwRfb…

Hakeem Lab is hiring a Visiting Fellow! Come join our team PATRU@Emory Emory Vaccine Center Emory University! At least 2 years of lab experience in Immunology or a related field. MSc preferred but not a must.

We’re hiring - please reach out if you’d like to join us at MD Anderson Cancer Center on our quest to develop new immunotherapies/cell therapies for the treatment of lung cancer. jobs.mdanderson.org/search/jobdeta…

#ASCO24 Non-smoking Lung Cancer Ranked 5Th in Global Cancer Deaths in the world

🙌🧬It’s official: the first TCR gene therapy for the treatment of cancer received U.S. FDA approval this evening. A milestone event for the oncology community and the 2nd cell therapy approved for solid cancers! Adaptimmune #Tcellpower adaptimmune.com/investors-and-…

PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease - Albert Koong, MD PhD Ethan Ludmir MD Chad Tang, MD MD Anderson Cancer Center Alexander Sherry Tharak Bathala Cara Haymaker Alexandre Reuben, Ph.D. Albert Koong, MD PhD oncodaily.com/blog/121538/ #OncoDaily #Oncology #Cancer

Today we welcome more than 100 new students to the Graduate School. We look forward to seeing where their journeys will take them. #WeAreGSBS #orientation2024

“By working with the patient-led advocacy groups, it’s an opportunity for me to make sure that the work we are doing in the lab has a direct impact on patient outcomes.” Alexandre Reuben, Ph.D. MD Anderson Cancer Center Learn more: brnw.ch/21wLWhE #lcsm #lungcancer #lungevityresearch

This webinar features Jill Feldman & Laura Book from EGFR Resisters & Dr Alexandre Reuben Alexandre Reuben, Ph.D. from MD Anderson a 2023 EGFR Resisters/LUNGevity Foundation grant recipient Moderated by Dr. Upal Basu Roy they discuss engineering T cells to treat lung cancer lungevity.canto.com/b/MS9BB